Topic Highlight
Copyright ©2008 The WJG Press and Baishideng.
World J Gastroenterol. Jun 7, 2008; 14(21): 3313-3327
Published online Jun 7, 2008. doi: 10.3748/wjg.14.3313
Table 7 Randomized, double-blind, placebo-controlled trials on ursodeoxycholic acid administration to patients with primary biliary cirrhosis
First authorNo. of patientsStudy design and duration of follow upUDCA effects on
PruritusHistologySurvival
Poupon[191]1462 yrImprovedImprovedNo effect
Heathcote[192]2222 yrNo effectImprovedNo effect
Lindor[193]180Mean follow up: 2 yrNo effectNo effectNo effect
Combes[194]1512 yrImprovedImproved (early stages)No effect
Eriksson[195]1162 yr + 2 yr as open trial (UDCA)No effectNo effectNo effect
Pares[196]192Mean follow up: 3.4 yrImprovedImprovedNo effect
Papatheodoritis[197]86Mean follow up 7.3 yr for UDCA 8.1 yr for controlsNot evaluatedNo effectNo effect